Persistent AF ablation is at another crossroads. Do you think PVI alone is sufficient, in which case why map? Instead perhaps you feel that a fixed lesion set is always indicated. Or do any of the patient specific AF mapping tools offer real insight into fundamental mechanisms to target?
This debate session is 45 minutes in length and is comprised of one chair and two invited speakers. Each speaker has up to 15 minutes to present their case followed by a five minute rebuttal.
- To explain the rationale for alternative mapping strategies in persistent AF.
- To identify which cases mapping may guide patient tailored therapy
- To outline the anatomical approach to ablation of persistent AF with a fixed lesion set
- To recognize spatial heterogeneity of driver sites as a need for disease specific mapping.
- Electrophysiology Fellow
- Cardiology Fellow
- Physician Assistant
Chair - Gerhard Hindricks, MD. Heart Center - University of Leipzig, Leipzig, Germany
Protagonist - William H. Sauer, MD, FHRS, CCDS. University of Colorado, Denver, CO
Antagonist - Atul Verma, MD, FHRS. Southlake Regional Health Centre, Toronto, ON, Canada
Rebuttal - William H. Sauer, MD, FHRS, CCDS. University of Colorado, Denver, CO
Rebuttal - Atul Verma, MD, FHRS. Southlake Regional Health Centre, Toronto, ON, Canada
This enduring material supported in part by Biosense Webster.
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
DISCLOSURE OF FACULTY’S COMMERCIAL RELATIONSHIP(S)
It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).
Gerhard Hindricks, MD. - Research Grants; Abbott. Research Grants; Boston Scientific Corp.
William H. Sauer, MD, FHRS, CCDS. - Compensation for Services; Boston Scientific Corp., Abbott, Biosense Webster, Inc.. Research Grants; Biosense Webster, Inc.
Atul Verma, MD, FHRS. - Compensation for Services; Bayer HealthCare, LLC. Research Grants; Bayer HealthCare, LLC, Biotronik, Biosense Webster, Inc., Medtronic, Inc.
Mohammad Shenasa, MD, PhD, FHRS - Nothing to Disclose
Chloe Thomas – Nothing to Disclose
Russell Werlinich – Nothing to Disclose
REPORTING CONFLICT OF INTEREST OR BIAS IN A PRESENTATION
Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at http://www.hrsonline.org/About-HRS/Heart-Rhythm-Society-Governance/Conflict-of-Interest-Complaint-Form#axzz32C70AtsV or submit an email message to scientific.sessions@HRSonline.org.